|
|
|
|
|||||
|
|
|
Abbott Laboratories (NYSE:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now.
Abbott Laboratories (NYSE:ABT) has long been a household name in the healthcare world, offering products that reach millions of people every day. Its operations span several major areas, including prescription medicines, medical devices, diagnostics, and nutrition. The company’s portfolio is wide-ranging, covering glucose monitors that help manage diabetes, implantable heart devices, diagnostic tools used in hospitals and labs, and popular nutritional products like Ensure and Glucerna. With a presence in more than 160 countries, Abbott earns a significant portion of its revenue from international markets.
What really makes Abbott Laboratories (NYSE:ABT) stand out is its steady commitment to innovation. The company keeps introducing new technologies that make healthcare easier and more efficient. One clear example is its FreeStyle Libre glucose monitoring system, which has transformed how people with diabetes keep track of their blood sugar levels. Its broad global footprint also helps the company stay flexible with its supply chains and maintain close connections to diverse markets. In an industry constantly evolving due to competition and regulation, Abbott’s ability to adapt and innovate has been a driving force behind its lasting success.
Financially, Abbott Laboratories (NYSE:ABT) has built a reputation as a solid dividend stock. The company has raised its dividend for 53 consecutive years— an achievement that places it among the most consistent dividend payers in the market. Its current quarterly dividend stands at $0.59 per share, translating to a yield of around 1.76%. For investors seeking a stable, long-term holding in the healthcare sector, Abbott remains a solid and trusted choice.
While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Best BDC Stocks to Buy Now and Dividend Champions List: Top 15 Stocks to Buy.
Disclosure: None.
| Oct-28 | |
| Oct-28 | |
| Oct-26 | |
| Oct-22 | |
| Oct-22 | |
| Oct-21 | |
| Oct-20 | |
| Oct-17 | |
| Oct-17 | |
| Oct-17 | |
| Oct-16 | |
| Oct-16 | |
| Oct-16 | |
| Oct-16 | |
| Oct-16 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite